The discovery of immune checkpoint molecules such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) towards the end of the 20th century has led to an enhanced understanding of tumor immunosuppression [13,14]. Here, CTLA4 is linked to neoplasm.